Skip to main navigation Skip to search Skip to main content

Renaming low risk conditions labelled as cancer

  • Brooke Nickel
  • , Ray Moynihan
  • , Alexandra Barratt
  • , Juan P. Brito
  • , Kirsten McCaffery*
  • *Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

516 Downloads (Pure)

Abstract

[Extract] Removing the cancer label in low risk conditions that are unlikely to cause harm if left untreated may help reduce overdiagnosis and overtreatment, argue Brooke Nickel and colleagues

Evidence is mounting that disease labels affect people’s psychological responses and their decisions about management options.1 The use of more medicalised labels can increase both concern about illness and desire for more invasive treatment. For low risk lesions where there is evidence of overdiagnosis and previous calls to replace the term cancer, we consider the potential implications of removing the cancer label and how this may be achieved.
Original languageEnglish
Article numberk3322
Number of pages8
JournalBMJ (Online)
Volume362
DOIs
Publication statusPublished - 12 Aug 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Renaming low risk conditions labelled as cancer'. Together they form a unique fingerprint.

Cite this